Drug development and diagnostics without limitations
Slingshot’s revolutionary technology is a new paradigm for any cell-based application, including drug discovery, clinical trials, medical testing, and cell therapy manufacturing.
High Throughput + Precision Manufacturing
We envisioned limitless drug development when we founded this company over 10 years ago. Our R&D experience revealed the shortcomings of biologically-derived reagents, leading to unequal access to diagnostics and therapies.
We knew there had to be a better way. And there is.
We created FlowCytes™ using biochemistry and polymer chemistry. These synthetic cells are printed on demand. Slingshot’s technology lowers costs, shortens timelines, and enhances stability and accessibility.
Our mission is to accelerate the discovery of innovative diagnostics and treatments that will improve and extend human life.
We strive for global leadership in cell technologies to enhance health. By uniting minds worldwide, we advance science with passion. Through collaboration, we foster innovation and embrace diversity. Our partnerships with researchers help them achieve goals faster. We deliver quality products while adhering to ethical standards.
Our north star is to make healthcare more accessible around the world. We will do that by:
Advancing cell biology to drive innovative solutions
Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.
Making diagnostic testing simple and accessible
Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.
Making personalized therapeutics a reality
Our vision is to advance the understanding of cell biology, especially in cancer and rare diseases, to help scientists and physicians focus on what they do best—creating innovative cures to treat patients.
Leadership
The people building Slingshot.
Glenn Bilawsky
Chief Executive Officer
Nimisha Srivastava
Chief Operating Officer
Jim Snook
Senior Vice President, Global Sales
Toney Szeto
Vice President, Head of Finance
Josh Haydon
Director, Brand and Marketing Operations
Nicholas Perez
Associate Director of HR
Board of Directors
Advisors shaping our direction.
Dr. Jeffrey Kim
Founder, Board Director
Andrew Lee
Board Director
Patrick Weiss
Board Director
Corey Ritter
Board Director
Keith Crandell
Board Observer
Ron Silberman
Board Director
Philip Austin
Board Observer
Nicolas Barthelemy
Chair of The Board
Our Investors
